Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00215215 · ClinicalTrials.gov registry record · Phase 4
Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures
A Phase 4 study, sponsored by Cyberonics.
- Terminated
- Registry status
- Phase 4
- Development phase
- 360
- Enrollment target
NCT00215215 is a Phase 4 study that was terminated before completion, run by Cyberonics. The registered enrollment target is 360 participants.
The verdict
NCT00215215, a Phase 4 study, was terminated before completion, sponsored by Cyberonics.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 360 participants
- Enrollment target
Study Summary
To compare outcomes over 12 months of treatment with antiepileptic drugs (AEDs) alone or vagus nerve stimulation (VNS) therapy plus AEDs in patients who have partial seizures refractory to at least two, but not more than five, AEDs.
Interventions
- DEVICE Vagus Nerve Stimulation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2005-02 |
| Est. Completion | 2007-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00215215
The ClinicalTrials.gov registry entry for NCT00215215 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cyberonics, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vagus Nerve Stimulation Therapy is the first listed.
NCT00215215 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00215215 about?
NCT00215215 is a clinical study titled "Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures". To compare outcomes over 12 months of treatment with antiepileptic drugs (AEDs) alone or vagus nerve stimulation (VNS) therapy plus AEDs in patients who have partial seizures refractory to at least two, but not more than five, AEDs.
What is the current status of trial NCT00215215?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 360 participants. The study started on 2005-02. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00215215?
The interventions under investigation include: Vagus Nerve Stimulation Therapy (DEVICE).
Who is sponsoring clinical trial NCT00215215?
This trial is sponsored by Cyberonics, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.